Nuuvera Shortlisted for Cannabis Contract with the German Federal Institute for Drugs and Medical Devices

Nuuvera (TSXV:NUU) has announced that it has been shortlisted by the German Federal Institute for Drugs and Medical Devices for a contract to grow, process, store and delivery up to 600 kg of cannabis in Germany.
As quoted in the press release:

Over 100 interested undertakings answered BfArM’s initial call for competition. Nuuvera is one of 10 remaining bidders asked to submit an offer in the public procurement procedure.

Lorne Abony, CEO of Nuuvera Inc. stated, “We are tremendously excited about BfArM’s decision, and for the headway Nuuvera has made in Germany, which is one of the largest markets in the world to legalize cannabis for medical usage.”

Click here to read the full press release.